antalarmin has been researched along with Endometrioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appleyard, CB; Gorabi, V; Rana, M; Rivera-Lopez, LL; Torres-Reverón, A | 1 |
| Appleyard, CB; Flores, I; Rivera-Lopez, LL; Torres-Reverón, A | 1 |
2 other study(ies) available for antalarmin and Endometrioma
| Article | Year |
|---|---|
Short treatment with antalarmin alters adrenal gland receptors in the rat model of endometriosis.
Topics: Adrenal Glands; Animals; Disease Models, Animal; Endometriosis; Female; Pituitary-Adrenal System; Pyrimidines; Pyrroles; Rats; Receptors, Corticotropin-Releasing Hormone; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; RNA, Messenger; Up-Regulation | 2020 |
Antagonizing the corticotropin releasing hormone receptor 1 with antalarmin reduces the progression of endometriosis.
Topics: Animals; Disease Models, Animal; Disease Progression; Endometriosis; Female; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Treatment Outcome | 2018 |